Kim P. Kamdar, Director at Evofem Biosciences, Inc. (EVFM), bought 10,000 shares at $1.17 ($12K) on 2021-06-18, disclosed to the SEC on 2021-06-21.
Open-market purchase of $12k EVFM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| EVFM | BUY | 2020-06-16 | $15K | — | Filing → |
| OBLN | BUY | 2019-08-08 | $50K | — | Filing → |
| EVFM | SELL | 2019-05-23 | $3K | — | Filing → |